Kohima, October 16 (MExN): Towards the objective of creating more awareness and treatment literacy with regard to the new treatment drugs for Viral Hepatitis C (HCV), ARK Foundation with support from the Department of Social Welfare, Nagaland conducted a series of virtual programme.
It was held in collaborated with Zion Welfare Society, Wokha, KBCA, Noklak and DAPCU, Kiphire under the banner ‘treatment literacy on hepatitis C’ with injecting drug users and staff of the NGOs on October 10, 15 and 16 respectively.
Ketho Angami, President, ARK Foundation facilitated as the resource person. The sessions covered included Hepatitis as a disease of the Liver, Its routes of transmission, test and diagnostics and treatment with the new oral regimens known as directly acting antivirals (DAAs) under the National Viral Hepatitis Control Program (NVHCP).
According to a press release issued by ARK Foundation, the participants were informed on the new treatment drugs namely “Sofosbuvir in combination with Daclatasvir or Velpatasvir with the Genotype test not a requisite anymore. This is so because the new drugs called DAAs works across all the genotype and treatment period is ideally for a three months course. These drugs shows treatment cure rate as high as 96% with minimal side effects.”
It was followed by question and answer session.
